Literature DB >> 7750164

Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin.

Z Zhang1, J E Riviere, N A Monteiro-Riviere.   

Abstract

Sulfur mustard (bis(2-chloroethyl)sulfide, HD), a bifunctional alkylating agent, causes severe cutaneous injury, including cell death, edema and vesication. However, the mechanisms underlying HD-induced cutaneous toxicity remain undefined. The isolated perfused porcine skin flap (IPPSF) has been utilized to investigate dermal toxic compounds and pharmacological intervention. In this study, 4 compounds with different pharmacological mechanisms were tested for their ability to prevent the dark basal cell formation, vesication and vascular response charcteristic of exposure to HD in the IPPSF. Reduction of HD-induced dark basal cells was observed in IPPSFs perfused with sodium thiosulfate and cysteine, which are HD scavengers; niacinamide, a possible NAD+ stabilizer and an inhibitor of poly (ADP-ribose) polymerase; or indomethacin, a cyclooxygenase inhibitor, respectively. Treatments with niacinamide and indomethacin, but not sodium thiosulfate or cysteine, resulted in an inhibition of the vascular response in IPPSF exposed to HD. Microvesicles caused by HD were only partially prevented in the indomethacin-perfused IPPSFs. These data suggest that none of these agents alone would be successful antivesicant agents and different mechanisms are involved in production of HD-induced dark basal cells, microvesicles and the vascular response; unfortunately, blocking of the cellular toxicity as evidenced by dark basal cell formation did not prevent vesication, suggesting that other mechanisms must be operative and that there is a multistep, biochemical process that leads to a final lesion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750164     DOI: 10.1016/0009-2797(94)03596-z

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  6 in total

1.  Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.

Authors:  Yoke-Chen Chang; James D Wang; Rita A Hahn; Marion K Gordon; Laurie B Joseph; Diane E Heck; Ned D Heindel; Sherri C Young; Patrick J Sinko; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-13       Impact factor: 4.219

Review 2.  Oxidants and antioxidants in sulfur mustard-induced injury.

Authors:  Jeffrey D Laskin; Adrienne T Black; Yi-Hua Jan; Patrick J Sinko; Ned D Heindel; Vasanthi Sunil; Diane E Heck; Debra L Laskin
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

Review 3.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

4.  Assessment of sulfur mustard interaction with basement membrane components.

Authors:  Z Zhang; B P Peters; N A Monteiro-Riviere
Journal:  Cell Biol Toxicol       Date:  1995-04       Impact factor: 6.691

5.  Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase.

Authors:  Zohreh Poursaleh; Ali Amini Harandi; Ensieh Vahedi; Mostafa Ghanei
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

6.  Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.

Authors:  Johannes Wohlrab; Nikola Bangemann; Anke Kleine-Tebbe; Marc Thill; Sherko Kümmel; Eva-Maria Grischke; Rainer Richter; Sophie Seite; Diana Lüftner
Journal:  Breast Cancer (Dove Med Press)       Date:  2014-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.